227 related articles for article (PubMed ID: 19706757)
21. Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population.
Paszkowska-Szczur K; Scott RJ; Górski B; Cybulski C; Kurzawski G; Dymerska D; Gupta S; van de Wetering T; Masojć B; Kashyap A; Gapska P; Gromowski T; Kładny J; Lubiński J; Dębniak T
Mol Biol Rep; 2015 Mar; 42(3):755-64. PubMed ID: 25391773
[TBL] [Abstract][Full Text] [Related]
22. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer.
Zhu Y; Lai M; Yang H; Lin J; Huang M; Grossman HB; Dinney CP; Wu X
Carcinogenesis; 2007 Mar; 28(3):698-703. PubMed ID: 17052994
[TBL] [Abstract][Full Text] [Related]
23. The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder.
Sak SC; Barrett JH; Paul AB; Bishop DT; Kiltie AE
Br J Cancer; 2005 Jun; 92(12):2262-5. PubMed ID: 15886698
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study.
Matullo G; Guarrera S; Sacerdote C; Polidoro S; Davico L; Gamberini S; Karagas M; Casetta G; Rolle L; Piazza A; Vineis P
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2569-78. PubMed ID: 16284380
[TBL] [Abstract][Full Text] [Related]
25. Polymorphism of DNA repair genes OGG1, XRCC1, XPD and ERCC6 in bladder cancer in Belarus.
Ramaniuk VP; Nikitchenko NV; Savina NV; Kuzhir TD; Rolevich AI; Krasny SA; Sushinsky VE; Goncharova RI
Biomarkers; 2014 Sep; 19(6):509-16. PubMed ID: 25089939
[TBL] [Abstract][Full Text] [Related]
26. New polymorphisms of Xeroderma Pigmentosum DNA repair genes in myelodysplastic syndrome.
Santiago SP; Junior HLR; de Sousa JC; de Paula Borges D; de Oliveira RTG; Farias IR; Costa MB; Maia ARS; da Nóbrega Ito M; Magalhães SMM; Pinheiro RF
Leuk Res; 2017 Jul; 58():73-82. PubMed ID: 28472728
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
[TBL] [Abstract][Full Text] [Related]
28. Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study.
Agalliu I; Kwon EM; Salinas CA; Koopmeiners JS; Ostrander EA; Stanford JL
Cancer Causes Control; 2010 Feb; 21(2):289-300. PubMed ID: 19902366
[TBL] [Abstract][Full Text] [Related]
29. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
Gu J; Zhao H; Dinney CP; Zhu Y; Leibovici D; Bermejo CE; Grossman HB; Wu X
Clin Cancer Res; 2005 Feb; 11(4):1408-15. PubMed ID: 15746040
[TBL] [Abstract][Full Text] [Related]
30. XPD polymorphisms, cigarette smoking, and bladder cancer risk: a meta-analysis.
Wang M; Gu D; Zhang Z; Zhou J; Zhang Z
J Toxicol Environ Health A; 2009; 72(11-12):698-705. PubMed ID: 19492231
[TBL] [Abstract][Full Text] [Related]
31. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk.
Sak SC; Barrett JH; Paul AB; Bishop DT; Kiltie AE
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2537-41. PubMed ID: 17164382
[TBL] [Abstract][Full Text] [Related]
33. DNA repair gene XRCC1 polymorphisms and bladder cancer risk.
Sak SC; Barrett JH; Paul AB; Bishop DT; Kiltie AE
BMC Genet; 2007 Apr; 8():13. PubMed ID: 17425776
[TBL] [Abstract][Full Text] [Related]
34. High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk.
Chen M; Kamat AM; Huang M; Grossman HB; Dinney CP; Lerner SP; Wu X; Gu J
Carcinogenesis; 2007 Oct; 28(10):2160-5. PubMed ID: 17728339
[TBL] [Abstract][Full Text] [Related]
35. Association between DNA repair gene polymorphisms and p53 alterations in Japanese patients with muscle-invasive bladder cancer.
Sakano S; Matsumoto H; Yamamoto Y; Kawai Y; Eguchi S; Ohmi C; Matsuyama H; Naito K
Pathobiology; 2006; 73(6):295-303. PubMed ID: 17374967
[TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk.
Gao W; Romkes M; Zhong S; Nukui T; Persad RA; Smith PJ; Branch R; Keohavong P
Oncol Rep; 2010 Jul; 24(1):257-62. PubMed ID: 20514470
[TBL] [Abstract][Full Text] [Related]
37. Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk.
Huang WY; Berndt SI; Kang D; Chatterjee N; Chanock SJ; Yeager M; Welch R; Bresalier RS; Weissfeld JL; Hayes RB
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):306-11. PubMed ID: 16492920
[TBL] [Abstract][Full Text] [Related]
38. Population study of genetic polymorphisms and superficial bladder cancer risk in Han-Chinese smokers in Shanghai.
Wen H; Ding Q; Fang ZJ; Xia GW; Fang J
Int Urol Nephrol; 2009 Dec; 41(4):855-64. PubMed ID: 19350405
[TBL] [Abstract][Full Text] [Related]
39. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility.
Andrew AS; Nelson HH; Kelsey KT; Moore JH; Meng AC; Casella DP; Tosteson TD; Schned AR; Karagas MR
Carcinogenesis; 2006 May; 27(5):1030-7. PubMed ID: 16311243
[TBL] [Abstract][Full Text] [Related]
40. Association between CCND1 and XPC polymorphisms and bladder cancer risk: a meta-analysis based on 15 case-control studies.
Wang Y; Li Z; Liu N; Zhang G
Tumour Biol; 2014 Apr; 35(4):3155-65. PubMed ID: 24264314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
